XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Balance Sheets - EUR (€)
€ in Millions
Jun. 30, 2024
Dec. 31, 2023
Assets    
Property, plant and equipment owned € 10,264 € 10,160
Right-of-use assets 1,616 1,654
Goodwill 50,080 49,404
Other intangible assets 26,653 24,319
Investments accounted for using the equity method 315 424
Other non-current assets 3,333 3,218
Non-current income tax assets 129 188
Deferred tax assets 7,284 6,427
Non-current assets 99,674 95,794
Inventories 10,609 9,666
Accounts receivable 8,510 8,433
Other current assets 3,870 3,455
Current income tax assets 295 391
Cash and cash equivalents 6,795 8,710
Current assets 30,079 30,655
Assets held for sale or exchange 2 15
TOTAL ASSETS 129,755 126,464
Equity and liabilities    
Equity attributable to equity holders of Sanofi 72,690 74,040
Equity attributable to non-controlling interests 307 313
Total equity 72,997 74,353
Long-term debt 12,503 14,347
Non-current lease liabilities 1,733 1,755
Non-current liabilities related to business combinations and to non-controlling interests 527 [1] 501
Non-current provisions and other non-current liabilities 8,219 7,602
Non-current income tax liabilities 1,949 1,842
Deferred tax liabilities 1,800 1,857
Non-current liabilities 26,731 27,904
Accounts payable 7,433 7,328
Current liabilities related to business combinations and to non-controlling interests 201 [1] 208
Current provisions and other current liabilities 12,746 13,741
Current income tax liabilities 132 597
Current lease liabilities 279 275
Short-term debt and current portion of long-term debt 9,236 2,045
Current liabilities 30,027 24,194
Liabilities related to assets held for sale or exchange 0 13
TOTAL EQUITY AND LIABILITIES € 129,755 € 126,464
[1] As of January 1, 2024, this comprised a non-current portion of €501 million and a current portion of €208 million.